Aysel Heckel

Aysel Heckel currently serves as the Head of Commercial Operations at BioDot, Inc. since July 2025. Prior experience includes the role of Vice President of Sales North America at Astrix from April 2024 to March 2025, where contributions supported scientific IT consulting for various sectors including pharma and biotech. At Benchling from April 2022 to September 2023, Aysel led the Mid-Market Sales team, successfully navigating a reduction in force while exceeding team goals. Previously, Aysel was the VP Sales & Support for North America at Oxford Gene Technology, focusing on molecular genetics reagents from January 2016 to July 2021. Earlier roles include Director of Global Clinical Solutions Sales at QIAGEN, Next Gen Sequencing Segment Manager at Ingenuity Systems, District Sales Manager and Translational Genomics Segment Manager at Illumina, and Sales/Marketing Manager at Roche Diagnostics. Aysel holds a Bachelor’s Degree in Biochemistry from Texas A&M University, earned between 1984 and 1988.